Vanda Pharmaceuticals Inc. - VNDA

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 17
Latest filed: Nov 05, 2026
Form Count
4 9
8-K 4
SCHEDULE 13G 3
SCHEDULE 13G/A 1

Latest files

Filed Form Report period Accession SEC
Nov 05, 2026 4 Nov 03, 2026 0001193125-26-449902 View
Oct 28, 2026 8-K Oct 28, 2026 0001628280-26-067886 View
Oct 27, 2026 SCHEDULE 13G — 0002052113-26-001132 View
Oct 09, 2026 SCHEDULE 13G/A — 0001104659-26-115112 View
Aug 19, 2026 SCHEDULE 13G — 0001104659-26-098866 View
Aug 13, 2026 SCHEDULE 13G — 0001167557-26-000170 View
Aug 05, 2026 8-K Aug 05, 2026 0001628280-26-053308 View
Jun 08, 2026 4 Jun 04, 2026 0001193125-26-261800 View
Jun 08, 2026 4 Jun 04, 2026 0001193125-26-261806 View
Jun 08, 2026 4 Jun 04, 2026 0001193125-26-261811 View
Jun 08, 2026 4 Jun 04, 2026 0001193125-26-261871 View
Jun 08, 2026 4 Jun 04, 2026 0001193125-26-261768 View
Jun 08, 2026 4 Jun 04, 2026 0001193125-26-261782 View
Jun 08, 2026 4 Jun 04, 2026 0001193125-26-261790 View
Jun 05, 2026 8-K Jun 04, 2026 0001628280-26-041298 View
May 20, 2026 4 May 18, 2026 0001802653-26-000003 View
May 06, 2026 8-K May 06, 2026 0001628280-26-031241 View